Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2012
08/02/2012WO2012101065A2 Pyrimidine biaryl amine compounds and their uses
08/02/2012WO2012101062A1 Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses
08/02/2012WO2012101013A1 Substituted pyridinyl-pyrimidines and their use as medicaments
08/02/2012WO2012100722A1 Process for preparing racemic nicotine
08/02/2012WO2012100704A1 Chiral low-toxicity cb1 receptor inhibitor, preparation method therefor, and use thereof
08/02/2012WO2012083048A3 Anti-viral compounds
08/02/2012WO2012078519A3 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
08/02/2012WO2012076704A3 Pyrazole compounds for controlling invertebrate pests
08/02/2012WO2012075362A3 Chemokine cxcr4 receptor modulators and used related thereto
08/02/2012WO2012063085A3 Drug derivatives
08/02/2012WO2012061418A3 Benzamides and nicotinamides as syk modulators
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120197022 Process for the resolution of (r,s)-nicotine
08/02/2012US20120197021 Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
08/02/2012US20120197018 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
08/02/2012US20120197014 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
08/02/2012US20120196905 Synthetic compounds and methods to decrease nicotine self-administration
08/02/2012US20120196901 Tertiary amide orexin receptor antagonists
08/02/2012US20120196900 Pyridine non-classical cannabinoid compounds and related methods of use
08/02/2012US20120196897 New compounds
08/02/2012US20120196896 Treatment for Oxidative Stress and/or Hypertension
08/02/2012US20120196885 New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196880 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196864 Prophylactic or therapeutic agent for cancer
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196859 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
08/02/2012US20120196856 Aryl aminopyridine pde10 inhibitors
08/02/2012US20120196851 Wnt pathway antagonists
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196838 Compounds for inflammation and immune-related uses
08/02/2012US20120196819 Animal treatments
08/02/2012US20120195887 Inhibitor Compounds and Cancer Treatment Methods
08/02/2012US20120194894 Electrochromic compound, electrochromic composition, and display element
08/02/2012US20120193617 Low-molecular compound, polymer, electronic-device material, composition for electronic device, organic electroluminescent element, organic solar cell element, display and lighting
08/02/2012US20120193614 Host material for lighting devices
08/02/2012US20120192880 Tobacco-derived casing composition
08/02/2012DE112010001898T5 Insektizide Pyridinverbindungen Insecticides pyridine
08/02/2012CA2825925A1 Method for producing di(arylamino)aryl compound and synthetic intermediate therefor
08/02/2012CA2825906A1 Compounds for the reduction of .beta.-amyloid production
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825134A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012CA2824536A1 Protease activated receptor 2 (par2) antagonists
08/02/2012CA2823804A1 Novel tetrahydroquinoline derivatives
08/02/2012CA2822120A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/01/2012EP2481736A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/01/2012EP2481735A1 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
08/01/2012EP2481734A1 Method for preparing halofuginone derivative
08/01/2012EP2481731A1 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
08/01/2012EP2481730A1 Insecticidal (1,3,5)-triazinyl phenyl hydrazones
08/01/2012EP2481729A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases
08/01/2012EP2481724A1 Method for producing hydrazine compound, and production intermediates of hydrazine compound and methods for producing the intermediates
08/01/2012EP2481723A2 Substituted tetracycline compounds
08/01/2012EP2480537A1 Aminoquinazoline compounds for combating invertebrate pests
08/01/2012EP2480533A1 Heterocyclic antiviral compounds
08/01/2012EP2480531A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
08/01/2012EP2480530A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
08/01/2012EP2480232A1 Disubstituted ]4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones
08/01/2012EP2480086A1 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
08/01/2012EP2265273B1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
08/01/2012EP2262770B1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
08/01/2012EP2155201B1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
08/01/2012EP2099501B1 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
08/01/2012EP2097385B1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
08/01/2012EP1994004B1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
08/01/2012EP1871749B1 Selurampanel
08/01/2012EP1869011B1 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
08/01/2012EP1856098B1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/01/2012EP1753421B1 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
08/01/2012EP1708701B1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/01/2012EP1521808B1 Compositions and inks containing disazo dyes
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012CN1918137B Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625803A Pharmaceutically useful heterocycle-substituted lactams
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102625798A Substituted quinolines for use as VEGF inhibitors
08/01/2012CN102625797A Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
08/01/2012CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/01/2012CN102617555A Preparation method of lansoprazole
08/01/2012CN102617554A Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof
08/01/2012CN102617553A Agricultural ryanodine receptor activator and preparation method and application thereof
08/01/2012CN102617552A Crystallizing method for preparing alpha crystal form methanesulfonic acid imatinib
08/01/2012CN102617551A Anthranilic diamide compound containing difluoro (methylene) methyl
08/01/2012CN102617550A Method for treating imazapyr-containing herbicide mother liquor
08/01/2012CN102617549A Method for preparing imatinib mesylate beta crystalline form
08/01/2012CN102617548A Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof
08/01/2012CN102617547A Method for preparing racemic nicotine
08/01/2012CN102617478A Synthesis of benzimidazole, oxazole and thiazole derivatives and application thereof
08/01/2012CN102617472A Preparation method of tetra-substituted olefin and its pyrazole derivative
08/01/2012CN102617464A fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
08/01/2012CN102617463A Quinoline derivative and quinazoline derivative and preparation method thereof
08/01/2012CN102617451A Pipradrol derivatives with pesticidal activity as well as preparation and application thereof
08/01/2012CN102086468B Compound for preventing and treating human papillomavirus infectious diseases and screening method thereof
08/01/2012CN101863880B Fasudil hydrochloride compound and novel method thereof
07/2012
07/31/2012US8232405 Benzylpiperizine compound
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/31/2012US8232312 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 1080